F
Ford Motor Company
F lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve, though they disagree widely on how much.
VENU
Venu Holding Corporation
There isn't enough reported data to score VENU yet.
F Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Under pressure | |
| Strong |
F's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
VENU Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
VENU's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
F PE Valuation
F has no meaningful PE right now: it lost money over the past year.
VENU PE Valuation
VENU has no meaningful PE right now: it lost money over the past year.
F Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect F's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
VENU Forward outlook
There aren't enough analyst estimates for VENU to show an outlook.
F Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | — |
| Q3 2026 | -$1.97 | -270% |
| Q2 2026 | -$1.87 | -340% |
| Q1 2026 | -$1.55 | -224% |
| Q4 2025 | -$2.06 | -241% |
| Q3 2025 | $1.16 | +32% |
| Q2 2025 | $0.78 | -19% |
| Q1 2025 | $1.25 | +29% |
| Q4 2024 | $1.46 | +35% |
F has swung to a loss: it lost $1.97 per share over the past year, after a profit the year before.
VENU Earnings Per Share
VENU has the edge over F in the latest year-over-year earnings comparison.
F Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49.5B | -2% |
| Q2 2026 | $48.3B | -3.8% |
| Q1 2026 | $43.3B | +6.4% |
| Q4 2025 | $45.9B | -4.8% |
| Q3 2025 | $50.5B | +9.4% |
| Q2 2025 | $50.2B | +5% |
| Q1 2025 | $40.7B | -5% |
| Q4 2024 | $48.2B | +4.9% |
F's revenue grew through 2023 and has held roughly level since: $49.5B last quarter, down 2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.9% | -0.1 points |
| Q2 2026 | 1.3% | +0.3 points |
| Q1 2026 | 5.4% | +4.6 points |
| Q4 2025 | -25% | -28 points |
| Q3 2025 | 3.1% | +1.2 points |
| Q2 2025 | 1% | -2.9 points |
| Q1 2025 | 0.8% | -2.1 points |
| Q4 2024 | 2.5% | +3.1 points |
F has the edge over VENU on profitability, with a higher operating margin.
VENU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8M | +6.9% |
| Q1 2026 | $3.9M | +11% |
| Q4 2025 | $4.5M | +6.1% |
| Q3 2025 | $5.4M | -1.2% |
| Q2 2025 | $4.5M | +7.5% |
| Q1 2025 | $3.5M | -11% |
| Q4 2024 | $4.3M | +9.1% |
| Q3 2024 | $5.5M | +39% |
VENU has the edge over F on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -320% | -90 points |
| Q1 2026 | -294% | +235 points |
| Q4 2025 | -162% | -12 points |
| Q3 2025 | -185% | -118 points |
| Q2 2025 | -230% | -126 points |
| Q1 2025 | -530% | -201 points |
| Q4 2024 | -150% | -73 points |
| Q3 2024 | -67% | +3 points |
VENU's operating margin was −320% last quarter, down 90 points from the same quarter a year ago.
F Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.1B | -40% |
| Q2 2026 | $2B | -54% |
| Q1 2026 | -$1.1B | -157% |
| Q4 2025 | $1.1B | +108% |
| Q3 2025 | $5.3B | +50% |
| Q2 2025 | $4.2B | +24% |
| Q1 2025 | $1.9B | +$2.6B |
| Q4 2024 | $530M | +169% |
F still generates free cash flow, though less than at its 2020 peak: $5.1B over the past year.
VENU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$67.9M | -$50.3M |
| Q1 2026 | -$74.4M | -$43.3M |
| Q4 2025 | -$52.4M | -$31.9M |
| Q2 2025 | -$17.6M | -$4.1M |
| Q1 2025 | -$31.1M | -$19.4M |
| Q4 2024 | -$20.4M | -$10.1M |
VENU has burned cash in almost every quarter: −$228M over the past year, against −$83M the year before.
F Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.2% | +89M shares |
| 1 year | +0.7% | +28M shares |
| 3 years | +0.6% | +26M shares |
| 5 years | +1% | +40M shares |
| Available history | +1.8% | +72M shares |
F has the edge over VENU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $311M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $150M |
F spent $311M buying back its own shares over the past year, up 107% from the year before.
VENU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +12.4M shares |
| 1 year | +59% | +22M shares |
VENU has 59M diluted shares, up 59% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
F Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.5x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q1 2026 | -2.0x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.2x | Net Cash |
| Q1 2025 | -1.8x | Net Cash |
| Q4 2024 | -1.8x | Net Cash |
F has more cash than debt.
VENU Net Leverage
VENU's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
F Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 19.6 | Oversold |
F's weekly RSI is 41 (neutral) and its Stochastic is 20 (oversold).
VENU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.1 | Oversold |
| Stochastic | 15.7 | Oversold |
VENU's weekly RSI is 27 (oversold) and its Stochastic is 16 (oversold).
F PE vs Consumer Cyclical Sector
| Metric | F | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
F has no meaningful PE right now: it lost money over the past year.
VENU PE vs Consumer Cyclical Sector
VENU has no meaningful PE right now: it lost money over the past year.
F Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.2 | 2.5% below |
| 20 week MA | $13.3 | 11% below |
| 50 week MA | $13.4 | 11% below |
| 100 week MA | $12.1 | 2% below |
| 200 week MA | $12.1 | 1.4% below |
VENU has stronger trend alignment. F is above 0 of 5 weekly averages versus VENU above 0 of 4.
VENU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.32 | 5.3% below |
| 20 week MA | $1.76 | 29% below |
| 50 week MA | $3.95 | 68% below |
| 100 week MA | $7.49 | 83% below |
VENU is in a downtrend: it's below all four of its weekly moving averages, and 83% below its 100-week average.
F Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.36 | $8.86 | -5.3% |
| 2021 | $8.86 | $20.3 | +129% |
| 2022 | $20.3 | $11.4 | -44% |
| 2023 | $11.4 | $12.2 | +7.3% |
| 2024 | $12.2 | $10.0 | -18% |
| 2025 | $10.0 | $13.3 | +33% |
| 2026 YTD | $13.3 | $11.9 | -11% |
F has the edge over VENU on returns for 2026, with the stronger performance.
VENU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $10.8 | $9.74 | -9.8% |
| 2025 | $9.74 | $8.17 | -16% |
| 2026 YTD | $8.17 | $1.25 | -85% |
VENU has finished every year since 2024 lower, and it's down 85% so far in 2026.